TABLE 1.
Demographics, treatments, and illness details for human post-mortem samples from patients with schizophrenia and controls.
| Case ID | Diagnostic | Gender | Age (years) | PMI (h) | Medication |
| 1557 | Control | M | 86 | 7 | NA |
| 1679 | Control | F | 90 | 14 | NA |
| 1694 | Control | M | 58 | 5 | NA |
| 1752 | Control | F | 88 | 24 | NA |
| 1818 | Control | M | 78 | 5 | NA |
| 1858 | Control | F | 83 | 7 | NA |
| 1870 | Control | F | 97 | 7 | NA |
| 1888 | Control | F | 93 | 6 | NA |
| 1937 | Control | F | 83 | 8 | NA |
| 1949 | Control | M | 86 | 8 | NA |
| 0810 | Control | F | 81 | 23 | NA |
| 1074 | Control | M | 31 | 17 | NA |
| 0364 | Control | F | 68 | 13 | NA |
| 0034 | Control | M | 64 | 4 | NA |
| 0839 | Control | M | 56 | 4 | NA |
| 0162 | Control | F | 71 | 8 | NA |
| 0024 | Control | F | 60 | 15 | NA |
| 0044 | Control | M | 39 | 4 | NA |
| 1491 | Control | M | 83 | 13 | NA |
| 1563 | Control | M | 79 | 5 | NA |
| 1570 | Control | F | 86 | 4 | NA |
| 1697 | Control | M | 78 | 6 | NA |
| 1733 | Control | M | 76 | 11 | NA |
| 1774 | Control | F | 74 | 5 | NA |
| P_001 | Chronic residual schizophrenia | M | 34 | 2 | NA |
| P_003 | Chronic residual schizophrenia | M | 80 | 6 | NA |
| P_008 | Chronic residual schizophrenia | M | 74 | 7 | Levomepromazine 75 mg/day Haloperidol 15 mg/day |
| P_011 | Chronic residual schizophrenia | M | 76 | 7 | Quetiapine 250 mg/day |
| P_017 | Chronic paranoid schizophrenia | M | 69 | 8 | Quetiapine 500 mg/day |
| P_019 | Chronic residual schizophrenia | M | 79 | 3 | Levomepromazine 13 mg/day, Quetiapine 600 mg/day |
| P_020 | Chronic residual schizophrenia | M | 65 | 4 | Quetiapine 1000 mg/day, Amisulpride 800 mg/day |
| P_021 | Schizoaffective disorder | M | 82 | 4 | Haloperidol 15 mg/day, Olanzapine 20 mg/day |
| P_022 | Chronic residual schizophrenia | M | 79 | 9 | Perphenazine 40 mg/day, Thioridazine 100 mg/day, Sulpiride 200 mg/day, Haloperidol: 10 mg/day |
| P_025 | Chronic residual schizophrenia | M | 98 | 8 | NA |
| P_026 | Chronic residual schizophrenia | M | 77 | 6 | Olanzapine 20 mg/day |
| P_027 | Chronic residual schizophrenia | M | 84 | 3 | Olanzapine 15 mg/day |
| P_028 | Chronic residual schizophrenia | M | 79 | 3 | NA |
| P_029 | Chronic residual schizophrenia | M | 80 | 5 | Olanzapine 15 mg/day |
| P_032 | Chronic residual schizophrenia | M | 92 | 2 | Quetiapine 100 mg/day |
| P_033 | Chronic residual schizophrenia | M | 87 | 4 | Olanzapine 5 mg/day |
| P_034 | Chronic residual schizophrenia | M | 93 | 3 | NA |
| P_035 | Chronic schizophrenia. Paranoid type | M | 86 | 1 | Levomepromazine 5 mg/day |
| P_037 | Chronic residual schizophrenia | M | 74 | 9 | Levomepromazine 50 mg/day, Olanzapine 10 mg/day |
| P_038 | Chronic residual schizophrenia | M | 75 | 6 | Olanzapine 10 mg/day |
| P_041 | Delusional disorder – Erotomaniac type | F | 81 | 5 | NA |
| P_042 | Chronic residual schizophrenia | M | 77 | 2 | Risperidone 2 mg/day, Quetiapine 1000 mg/day |
| P_044 | Chronic disorganized schizophrenia | M | 78 | 8 | NA |
| P_045 | Chronic residual schizophrenia | F | 86 | 2 | Haloperidol 15 mg/day |
| P_046 | Chronic residual schizophrenia | M | 82 | 6 | Risperidone 2 mg/day |
| P_049 | Chronic residual schizophrenia | M | 79 | 7 | Haloperidol 3 mg/day |
| P_052 | Chronic residual schizophrenia | M | 81 | 6 | NA |
| P_053 | Schizophrenia. Paranoid type. In remission | M | 80 | 2 | NA |
| P_055 | Chronic residual schizophrenia | M | 76 | 5 | Sulpiride 200 mg/day |
| P_056 | Chronic residual schizophrenia | M | 83 | 4 | Quetiapine 50 mg/day |
| P_058 | Chronic residual schizophrenia | M | 87 | 9 | NA |
| P_059 | Chronic residual schizophrenia | M | 83 | 4 | Chlorpromazine 200 mg/day, Haloperidol 10 mg/day, Olanzapine 20 mg/day, Levomepromazine 100 mg/day, Perphenazine 30 mg/day, Tioproperazine 20 mg/day, |
| P_062 | Chronic residual schizophrenia | M | 81 | 8 | NA |
| P_064 | Chronic residual schizophrenia | M | 89 | 1 | NA |
| P_065 | Chronic residual schizophrenia | M | 76 | 8 | Perphenazine 4 mg/day, Olanzapine 5 mg/day |
| P_068 | Chronic residual schizophrenia | M | 90 | 3 | NA |
| P_069 | Chronic residual schizophrenia | M | 86 | 6 | NA |
| P_072 | Chronic residual schizophrenia | M | 83 | 6 | NA |
| P_074 | Chronic residual schizophrenia | M | 85 | 2 | Haloperidol 2 mg/day |
| P_076 | Chronic residual schizophrenia | M | 75 | 6 | Levomepromazine 25 mg/day, Olanzapine 10 mg/day |
| P_077 | Chronic disorganized schizophrenia | M | 84 | 3 | Amisulpride 200 mg/day |
| P_080 | Chronic residual schizophrenia | M | 81 | 2 | Zyprexa 10 mg/day, Haloperidol 3 mg/day; Olanzapine 5 mg/day, Tioridazine 150 mg/day, |
| P_084 | Chronic schizophrenia. Catatonic type | M | 71 | 8 | Quetiapine 300 mg/day, Olanzapine 40 mg/day |
| P_086 | Chronic schizophrenia. Catatonic type | M | 82 | 7 | NA |
| P_087 | Chronic residual schizophrenia | M | 74 | 4 | Quetiapine 350 mg/day, Haloperidol 5 mg/day, |
| P_089 | Chronic residual schizophrenia | M | 67 | 7 | Olanzapine 10 mg/day, Quetiapine 75 mg/day, Haloperidol 20 mg/day |
| P_091 | Chronic residual schizophrenia a | M | 91 | 3 | NA |
| P_092 | Chronic residual schizophrenia | M | 78 | 6 | Haloperidol 1 mg/day |
| P_093 | Chronic residual schizophrenia | M | 69 | 7 | Haloperidol 15 mg/day, Risperidone 12 mg/day, Olanzapine 30 mg/day |
| P_096 | Schizophrenia. Simple type | M | 58 | 2 | Haloperidol 15 mg/day |
| P_097 | Chronic residual schizophrenia | M | 50 | 2 | Haloperidol 15 mg/day |
| P_100 | Chronic residual schizophrenia | M | 69 | 3 | NA |
| P_102 | Chronic schizophrenia. Paranoid type | M | 64 | 3 | Olanzapine 20 mg/day |
PMI, Post-mortem interval; M, Male; F, Female; NA, Not applicable.